(Q33348477)

26 July 2017

title

The treatment of multiple myeloma with docetaxel (an ECOG study). (English)

1 reference

26 July 2017

1 reference

William R Friedenberg

1

1 reference

26 July 2017

David Graham

2

1 reference

26 July 2017

Philip Greipp

3

1 reference

26 July 2017

Emily Blood

4

1 reference

26 July 2017

Robert D Winston

5

1 reference

26 July 2017

publication date

1 August 2003

1 reference

26 July 2017

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

8

1 reference

26 July 2017

page(s)

751-754

1 reference

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

1 reference

7 January 2021

Taxol resistant mutants of Chinese hamster ovary cells: genetic biochemical, and cross-resistance studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

7 January 2021

Primary therapy of multiple myeloma with paclitaxel (taxol)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

7 January 2021

Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93)

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

7 January 2021

Confidence limits for probability of response in multistage phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2802%2900344-2

7 January 2021

10.1016/S0145-2126(02)00344-2

Identifiers

DOI

1 reference

26 July 2017

1 reference